Results 241 to 250 of about 2,372,359 (312)

An Integrated 5I Health Promotion Model for Enhancing Independence and Quality of Life Among Older Adults in Indonesia: A Community-Based Path Analysis Study. [PDF]

Int J Environ Res Public Health
Suwarni S, Kristiyanto A, Anantanyu S, Lestari A.   +3 more
europepmc   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

A Youth-Led Evaluation of Adolescent Involvement in a Project on Development of Guidelines for Adolescent Involvement in Health Research. [PDF]

Health Expect
Moore K, Wacker C, Hadfield K, Warraitch A.   +3 more
europepmc   +1 more source

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Editorial: The use of technology in mental health occupational therapy. [PDF]

Front Psychiatry
Tan BL, Champagne T.
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Promoting a vision of inclusion and improved health outcomes in childhood disability: the Child-FERST framework. [PDF]

BMJ Paediatr Open
Eliason SHY, Klein J, Ip A.
europepmc   +1 more source

Third-party disability among family caregivers of older adults with post-stroke disability in mainland China: a qualitative study based on the ICF framework. [PDF]

BMC Geriatr
Li N, Zhang Y, Gao Y, Qin J, Liao Y, Rong X, Yu H.   +6 more
europepmc   +1 more source